NICE is seeking more evidence on Mounjaro, which blunts appetite and helps manage blood glucose levels, despite previously approving a similar weekly injection called Wegovy.
Demand for these types of treatments has increased due to social media posts about people, often celebrities, shedding large amounts of weight.
Some people have been buying Ozempic, another injection for type 2 diabetes, off-label as a weight loss aid due to global shortages.
The NHS price of the pre-filled pens for Mounjaro has not been made public due to commercial sensitivities.
LONDON DAILY ARCHIVE
NICE Rejects Use of Mounjaro for NHS Diabetes Treatment Over Cost-Effectiveness Concerns
The National Institute for Health and Care Excellence (NICE) has rejected the use of Mounjaro, a new diabetes medicine, on the NHS due to concerns over its cost-effectiveness.
27 June 2023 · 07:45 UTC
